Suit against Genzyme gets major boost
Former investors say firm cheated them in buyback
A federal judge has given former shareholders of Genzyme's Corp.'s Biosurgery Division a major legal victory by ruling that their case against Genzyme can go forward. (Full article: 678 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly
